LOPALCO, GIUSEPPE
 Distribuzione geografica
Continente #
NA - Nord America 6.293
EU - Europa 1.195
AS - Asia 380
Continente sconosciuto - Info sul continente non disponibili 7
SA - Sud America 3
AF - Africa 1
OC - Oceania 1
Totale 7.880
Nazione #
US - Stati Uniti d'America 6.287
SE - Svezia 415
CN - Cina 320
IT - Italia 223
FR - Francia 219
GB - Regno Unito 89
DE - Germania 81
BE - Belgio 59
FI - Finlandia 55
VN - Vietnam 22
IE - Irlanda 18
IN - India 18
UA - Ucraina 12
IR - Iran 9
EU - Europa 7
CA - Canada 5
TR - Turchia 4
AT - Austria 3
CZ - Repubblica Ceca 3
HR - Croazia 3
ID - Indonesia 3
RO - Romania 3
BR - Brasile 2
PT - Portogallo 2
AL - Albania 1
AR - Argentina 1
AU - Australia 1
BG - Bulgaria 1
CH - Svizzera 1
DO - Repubblica Dominicana 1
ES - Italia 1
HK - Hong Kong 1
HU - Ungheria 1
IS - Islanda 1
JP - Giappone 1
LV - Lettonia 1
MN - Mongolia 1
NL - Olanda 1
NO - Norvegia 1
SI - Slovenia 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 7.880
Città #
Fairfield 1.056
Woodbridge 675
Houston 630
Chandler 545
Ashburn 513
Seattle 430
Ann Arbor 381
Cambridge 371
Nyköping 352
Wilmington 316
Lawrence 121
Roxbury 115
Beijing 101
Jacksonville 84
Bari 80
Des Moines 75
Nanjing 74
New York 66
Inglewood 64
Brussels 59
Princeton 56
San Diego 44
Shenyang 31
Dearborn 28
Paris 28
London 23
Dong Ket 21
Nanchang 20
Dublin 18
Brooklyn 16
Jiaxing 15
Redwood City 14
Hebei 13
Pune 13
Tianjin 12
Boardman 11
Changsha 11
San Mateo 11
Hounslow 9
Guangzhou 8
Ardabil 7
Kilburn 7
San Francisco 7
Brindisi 6
Giovinazzo 6
Hefei 6
Milan 6
Augusta 5
Indiana 5
Jinan 5
Falls Church 4
Leawood 4
Pescara 4
Prescot 4
Toronto 4
Washington 4
Boston 3
Cerignola 3
Chiswick 3
Detroit 3
Hangzhou 3
Helsinki 3
Islington 3
Norwalk 3
Ostwald 3
Simi Valley 3
Taizhou 3
Taranto 3
Vienna 3
Wiesbaden 3
Avegno 2
Bitonto 2
Castellamonte 2
Massa 2
Monmouth Junction 2
Nagold 2
New Bedfont 2
Ningbo 2
Nürnberg 2
Shanghai 2
Terlizzi 2
Verdellino 2
Zagreb 2
Zhengzhou 2
Zogno 2
Acton 1
Arlington 1
Atlanta 1
Brno 1
Budapest 1
Buffalo 1
Campo San Martino 1
Can Tho 1
Chapel Hill 1
Chicago 1
Chongqing 1
Dallas 1
Esslingen am Neckar 1
Florence 1
Gallarate 1
Totale 6.681
Nome #
Safety of Long-Term Biologic Therapy in Rheumatologic Patients With a Previously Resolved Hepatitis B Viral Infection 136
Efficacy and safety profile of anti-interleukin-1 treatment in Behçet’s disease: a multicenter retrospective study 127
Sarcopenia in Patients with Rheumatic Diseases: Prevalence and Associated Risk Factors 126
Cumulative retention rate of adalimumab in patients with Behçet's disease-related uveitis: a four-year follow-up study 117
Correlation between serum amyloid-A and serum levels of proinflammatory cytokines in patients with Behçet's disease 117
Basic characteristics of adults with periodic fever, aphthous stomatitis, pharyngitis, and adenopathy syndrome in comparison with the typical pediatric expression of disease 114
Autoimmunity and autoinflammation as the yin and yang of idiopathic recurrent acute pericarditis 113
Retinal vessels thrombosis as onset manifestation of systemic sclerosis: 3 clinical cases 107
Comparative efficacy between adalimumab and infliximab in the treatment of non-infectious intermediate uveitis, posterior uveitis, and panuveitis: a retrospective observational study of 107 patients 106
Auditory involvement in Behcet’s disease: relationship with demographic, clinical, and therapeutic characteristics 106
Refractory knee giant cell tumor of the synovial membrane treated with intra-articular injection of Infliximab: A case series and review of the literature 105
Ten-Year Retention Rate of Infliximab in Patients with Behçet's Disease-Related Uveitis 104
Interleukin-1 as a common denominator from autoinflammatory to autoimmune disorders: Premises, perils, and perspectives 104
Unveiling the Efficacy, Safety, and Tolerability of Anti-Interleukin-1 Treatment in Monogenic and Multifactorial Autoinflammatory Diseases 104
Interleukin (IL)-1 inhibition with anakinra and canakinumab in Behçet's disease-related uveitis: a multicenter retrospective observational study 103
Different switching rate of anti-TNF-α drugs in monotherapy and in combination with methotrexate in a cohort of rheumatoid arthritis patients in the real life 102
Management of Small Vessel Vasculitides 101
A Bayesian mixed treatment comparison of efficacy of biologics and small molecules in early rheumatoid arthritis 100
Mucocutaneous Involvement in Behçet's Disease: How Systemic Treatment Has Changed in the Last Decades and Future Perspectives 99
PFAPA syndrome and Behçet’s disease: a comparison of two medical entities based on the clinical interviews performed by three different specialists 98
Effectiveness and tuberculosis-related safety profile of interleukin-1 blocking agents in the management of Behçet's disease 98
Key facts and hot spots on tumor necrosis factor receptor-associated periodic syndrome 97
Tumor necrosis factor receptor-associated periodic syndrome managed with the couple canakinumab-alendronate 96
Paradoxical mucocutaneous flare in a case of Behçet’s disease treated with tocilizumab 95
Efficacy and safety of adalimumab in Behçet's disease-related uveitis: a multicenter retrospective observational study. 94
Proinflammatory cytokines and antiskin autoantibodies in patients with inherited epidermolysis bullosa 94
A false occult hepatitis B virus infection developed in a patient with psoriatic arthritis under infliximab and methotrexate therapy 93
Serum amyloid-A in Behçet's disease 92
Certolizumab Pegol treatment in Behcet's disease with different organ involvement: A multicenter retrospective observational study 92
Untangling the web of systemic autoinflammatory diseases 89
Relapsing Polychondritis: an Update on Pathogenesis, Clinical Features, Diagnostic Tools, and Therapeutic Perspectives 88
AB0836 Drug retention rate of the first tnf inhibitor in radiographic and non radiographic axial spondyloarthritis: data from a multicenter study 88
Efficacy of adalimumab and infliximab in recalcitrant retinal vasculitis inadequately responsive to other immunomodulatory therapies 87
null 86
AB0065 Possible Interplay Between Serum Amyloid-A and Pro-Inflammatory Cytokines Into the Pathogenesis of Behçet's Disease 86
A comprehensive comparison between pediatric and adult patients with periodic fever, aphthous stomatitis, pharyngitis, and cervical adenopathy (PFAPA) syndrome 85
Long-term retention rate of anakinra in adult onset Still’s disease and predictive factors for treatment response 84
Different roles of TNF inhibitors in acute anterior uveitis associated with ankylosing spondylitis: state of the art 83
Systemic Steroid Sparing Effect of Intravitreal Dexamethasone Implant in Chronic Noninfectious Uveitic Macular Edema 83
null 82
AB0452 Changes in Lipoproteins Associated with Tocilizumab Treatment Do not Influence the Atherogenic Index of Plasma of Rheumatoid Arthritis Patients: Table 1 82
null 81
Lipids and atherogenic indices fluctuation in rheumatoid arthritis patients on long-term tocilizumab treatment 81
null 80
The protean ocular involvement in monogenic autoinflammatory diseases: state of the art 80
Splenic Infarction as Only Manifestation of Antiphospholipid Syndrome in a Patient With Rheumatoid Arthritis 79
Longterm clinical outcomes in 420 patients with psoriatic arthritis taking anti-tumor necrosis factor drugs in real-world settings 76
Pain Processing and Vegetative Dysfunction in Fibromyalgia: A Study by Sympathetic Skin Response and Laser Evoked Potentials 75
AB0041 Serum Amyloid A Stimulates The Induction of Inflammatory Mediators in Monocytes from Behçet's Disease Patients: A Proof of Concept Study 75
null 74
null 72
null 72
Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study 72
Long-term retention rates of adalimumab and infliximab in non-infectious intermediate, posterior, and panuveitis 72
SAT0212 Pericardial Effusion Related To Systemic Sclerosis: A Possible Contribution of The Serum Levels of Adipokines and Interleukines 72
SAT0216 Chest Ultrasound Signs of Interstitial Lung Disease in Systemic Sclerosis Patients: A Comparison between High Resolution Chest Computed Tomography Findings 72
THU0153 The effect of 5-years b-dmards treatment on different 10-years cardiovascular risk scores applied in rheumatoid arthritispatients 72
null 71
null 70
IL-6 blockade in the management of non-infectious uveitis 70
AB0369 Adult-onset still’s disease treatment predictors at 1-year follow-up in a single rheumatologic centre experience 69
FRI0110 Methotrexate monotherapy in real life: a drug survival analysis. comparison between very early arthritis and early arthritis cohorts 67
Behçet's syndrome in Italy: a detailed retrospective analysis of 396 cases seen in 3 tertiary referral clinics 67
Biological therapies for the treatment of Behçet’s disease-related uveitis beyond TNF-alpha blockade: a narrative review 66
The role of biosimilars in uveitis: Long-term real-world outcomes of the switch from original to biosimilar TNF-alpha inhibitors 66
Predictors of sustained clinical response in patients with Behçet’s disease-related uveitis treated with infliximab and adalimumab 65
Critical regulation of Th17 cell differentiation by serum amyloid-A signalling in Behcet's disease 64
AB0245 PREDICTORS OF BIOLOGIC THERAPY DISCONTINUATION IN RHEUMATOID ARTHRITIS PATIENTS AFTER REMISSION ACHIEVEMENT: A MONOCENTRIC OBSERVATIONAL STUDY FROM BIOLOGIC APULIAN REGISTRY (BIOPURE) 64
null 62
null 62
Safety profile of biologic agents for Behçet's disease in a multicenter observational cohort study 62
Long-term safety of anti-TNF agents on the liver of patients with spondyloarthritis and potential occult hepatitis B viral infection: an observational multicentre study 61
Anakinra for corticosteroid-dependent and colchicine-resistant pericarditis: The IRAP (International Registry of Anakinra for Pericarditis) study 60
null 59
Putative role of serum amyloid-A and proinflammatory cytokines as biomarkers for behcet's disease 58
Influence of baseline modified Rheumatic Disease Comorbidity Index (mRDCI) on drug survival and effectiveness of biological treatment in patients affected with Rheumatoid arthritis, Spondyloarthritis and Psoriatic arthritis in real-world settings 58
THU0168 Relationships between body fat composition assessed with bioelectrical impedance analysis, serum adipokines and disease activity in patients with rheumatoid arthritis 57
Epidemiological profile of non-infectious uveitis from the rheumatologist's perspective: a survey from two tertiary referral centres in Italy 56
SAT0380 FIBROMYALGIA IS THE STRONGEST NEGATIVE PREDICTOR FOR THE ACHIEVEMENT OF EITHER REMISSION AND MINIMAL DISEASE ACTIVITY IN NAIVE PSORIATIC ARTHRITIS PATIENTS STARTING BIOLOGIC DRUGS 56
OP0129 Drug survival on anti-tnf-alpha in psoriatic arthritis patients with axial involvement and analysis of predictors 55
improvement of refractory dysphagia in patients with idiopathic inflammatory myopathies receveing immunoglubulin intravenous therapy 51
Influence of changes in cholesterol levels and disease activity on the 10 years cardiovascular risk estimated with different algorithms in rheumatoid arthritis patients 48
Different drug survival of first line tumour necrosis factor inhibitors in radiographic and non-radiographic axial spondyloarthritis: a multicentre retrospective survey 46
Improvement of Refractory Dysphagia in Patients with Idiopathic Inflammatory Myopathies Receveing Immunoglobulin Intravenous Therapy 45
Development and Implementation of the AIDA International Registry for Patients with Non-Infectious Scleritis 44
null 43
Effectiveness and safety profile of anakinra in a HLA-B27 positive patient with multiple sclerosis-associated uveitis 42
The autoinflammatory side of recurrent pericarditis: Enlightening the pathogenesis for a more rational treatment 42
null 41
null 41
Real-world effectiveness of apremilast in multirefractory mucosal involvement of Behçet's disease 39
Tomographic regression of pulmonary rheumatoid nodules under baricitinib therapy 38
Efficacy and Safety of Intravenous Immunoglobulin Treatment in Refractory Behcet's Disease with Different Organ Involvement: A Case Series 37
null 36
Prompt Clinical Response to Secukinumab in Patients with Axial Spondyloarthritis: Real Life Observational Data from Three Italian Referral Centers 35
null 35
Intravitreal Dexamethasone Implant as an Adjunct Weapon for Severe and Refractory Uveitis in Behçet's Disease 35
null 34
Effectiveness of TNF-α blockade in the treatment of refractory non-infectious scleritis: a multicentre study 33
Adalimumab effectively controls both anterior and posterior noninfectious uveitis associated with systemic inflammatory diseases: focus on Behçet’s syndrome 33
Totale 7.511
Categoria #
all - tutte 33.498
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.498


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019599 0 0 0 0 0 0 0 0 16 117 235 231
2019/20202.428 310 67 49 169 266 233 256 309 342 157 182 88
2020/20211.476 84 140 110 59 249 139 129 127 118 138 96 87
2021/2022952 72 39 20 37 39 81 63 51 70 79 118 283
2022/20231.520 211 189 122 116 113 234 40 196 205 17 53 24
2023/2024469 44 104 28 47 63 129 18 36 0 0 0 0
Totale 8.457